Latest Conference Articles

Patients Are the “Value” Focus in Cancer Care, Panelists Agree

Patients Are the “Value” Focus in Cancer Care, Panelists Agree

April 9th 2021, 8:18pm

Community Oncology Alliance

There are many sources, and definitions, of where the value in cancer care lies. In this panel discussion, a cancer survivor and patient advocate, an oncologist, and a benefits professional provided their perspectives on what value in cancer care means to them.

Dr Lalan Wilfong Discusses Growth in Remote Monitoring, Future of Value-Based Cancer Care

Dr Lalan Wilfong Discusses Growth in Remote Monitoring, Future of Value-Based Cancer Care

April 9th 2021, 6:30pm

Community Oncology Alliance

Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and cochair, Payment Reform, Community Oncology Alliance, speaks on the evolution of remote monitoring in cancer care and how value-based oncology may look in the near future.

Dr Edward Licitra on Aligning Patient, Physician Goals in Value-Based Cancer Care

Dr Edward Licitra on Aligning Patient, Physician Goals in Value-Based Cancer Care

April 9th 2021, 5:00pm

Community Oncology Alliance

Edward Licitra, MD, PhD, medical oncologist, Astera Health Partners, discusses his thoughts on what value-based cancer care entails and how physicians can best align their goals with those of the patient and health plan.

Palliative Care Encompasses Much More Than End-of-Life Care

Palliative Care Encompasses Much More Than End-of-Life Care

April 8th 2021, 10:00pm

Community Oncology Alliance

A popular misconception of palliative care is that it only has importance toward making patients comfortable at the end of their lives, noted a palliative care physician on the first day of the 2021 Community Oncology Conference, presented by the Community Oncology Alliance.

Kathy Oubre on Challenges, Benefits of Biosimilar Integration in Oncology

Kathy Oubre on Challenges, Benefits of Biosimilar Integration in Oncology

April 8th 2021, 8:00pm

Community Oncology Alliance

Kathy Oubre, MS, chief operating officer of Pontchartrain Cancer Center, discusses cost-saving implications of biosimilars in oncology, as well as several barriers that continue to impede their use.

Ted Okon Addresses Payment Reform in Oncology, Issues of 340B

Ted Okon Addresses Payment Reform in Oncology, Issues of 340B

April 8th 2021, 6:23pm

Community Oncology Alliance

Ted Okon, MBA, executive director of the Community Oncology Alliance, discusses what influence the new administration may have on payment reform in oncology and issues regarding the 340B drug pricing program.

The ABCs of Community Oncology Are Adaptability, Communication, and Flexibility

The ABCs of Community Oncology Are Adaptability, Communication, and Flexibility

April 8th 2021, 5:42pm

Community Oncology Alliance

Day 1 of this year’s virtual Community Oncology Conference opened with a panel discussion that touched on all things related to the COVID-19 pandemic, with leaders presenting a unified front.

Dr Jeff Patton Discusses COVID-19 Implications, Potential Takeaways at the Community Oncology Conference 2021

Dr Jeff Patton Discusses COVID-19 Implications, Potential Takeaways at the Community Oncology Conference 2021

April 7th 2021, 9:30pm

Community Oncology Alliance

Jeff Patton, MD, CEO, OneOncology, and chairman of the board, Tennessee Oncology, discusses what influence COVID-19 will have on discussions at the Community Oncology Conference 2021, as well as takeaways he hopes audience members and participants gain from the conference.

Dr Lalan Wilfong on the Upcoming Quality Metrics in Cancer Care Discussion at Community Oncology Conference 2021

Dr Lalan Wilfong on the Upcoming Quality Metrics in Cancer Care Discussion at Community Oncology Conference 2021

April 5th 2021, 6:00pm

Community Oncology Alliance

Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and co-chair, Payment Reform, Community Oncology Alliance, discusses implications of quality metrics in cancer care and what perspectives on the topic he is looking forward to hearing at the 2021 Community Oncology Conference.

Poster Roundup: Boosting Checkpoint Inhibitors, Resistant Mechanisms in Cholangiocarcinoma

Poster Roundup: Boosting Checkpoint Inhibitors, Resistant Mechanisms in Cholangiocarcinoma

April 4th 2021, 9:38pm

Cholangiocarcinoma Foundation Annual Conference

Research presented at the 2021 Cholangiocarcinoma Foundation Annual Meeting focused on precision medicine and therapeutic targets.